Diligence memo · auto-generated · as of July 2, 2026

Gastromedix, Inc.

Gastromedix, Inc. looks under-valued against its niche peers and is active on financing cadence.

SourceModeled below same-niche peers while still financing on rhythm — a potential mispricing worth a closer look.

Businessfiled

Gastromedix, Inc. operates in Other Health Care, based in IRVINE.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Gastromedix, Inc. has raised $30M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).

Largest single filing: $30M on —.

Valuation (modeled)modeled

Provath models Gastromedix, Inc. at approximately $107M (range $71M–$130M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.34× the median modeled value of Series B Other Health Care companies (458 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

No dated round to assess.

Comparablesmixed

Capital scale ranks ahead of 88% of Other Health Care peers (5377 compared).

Modeled value ranks above 81% of those peers.

Peoplefiled

1 named person on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.